newsfilter
← Latest News
Business Wire·

United Therapeutics Corporation Announces Additional $2 Billion Share Repurchase Authorization

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, announced today that the company’s Board of Directors has authorized a new share repurchase program for up to $2 billion of the company’s